FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1114411000001108: Lithium carbonate 200mg modified-release tablets 100 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22617501000001115 Lithium carbonate 200mg modified-release tablets 100 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22617601000001116 Lithium carbonate 200mg modified-release tablets 100 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lithium carbonate 200mg modified-release tablets 100 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Lithium carbonate 200mg modified-release tablets 100 tablet Is pack of Lithium carbonate 200mg m/r tablet false Inferred relationship Existential restriction modifier
Lithium carbonate 200mg modified-release tablets 100 tablet Has active ingredient Lithium carbonate false Inferred relationship Existential restriction modifier
Lithium carbonate 200mg modified-release tablets 100 tablet Has VMP Lithium carbonate 200mg modified-release tablets true Inferred relationship Existential restriction modifier
Lithium carbonate 200mg modified-release tablets 100 tablet VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Lithium carbonate 200mg modified-release tablets 100 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lithium carbonate 200mg modified-release tablets 100 tablet VMP prescribing status (attribute) Not recommended to prescribe as a VMP false Inferred relationship Existential restriction modifier
Lithium carbonate 200mg modified-release tablets 100 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lithium carbonate 200mg modified-release tablets 100 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Lithium carbonate 200mg modified-release tablets 100 tablet Has VMP Lithium carbonate 200mg m/r tablet false Inferred relationship Existential restriction modifier
Lithium carbonate 200mg modified-release tablets 100 tablet Has specific active ingredient Lithium carbonate true Inferred relationship Existential restriction modifier
Lithium carbonate 200mg modified-release tablets 100 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Lithium carbonate 200mg modified-release tablets 100 tablet VMP prescribing status (attribute) VMP not recommended to prescribe - brands not bioequivalent false Inferred relationship Existential restriction modifier
Lithium carbonate 200mg modified-release tablets 100 tablet Has VMP Lithium carbonate 200mg modified-release tablets false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Priadel 200 modified-release tablets (Sanofi-Synthelabo Ltd) 100 tablet 10 x 10 tablets Is a True Lithium carbonate 200mg modified-release tablets 100 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start